Mandate

Vinge and Kirkland & Ellis advises Baxter in connection with the acquisition of Gambro

December 05, 2012

Vinge and Kirkland & Ellis advises the global medical technology company Baxter International Inc. (“Baxter”) in connection with the acquisition of Gambro AB for an enterprise value of SEK 26.5 billion. Closing of the transaction is subject to applicable competition law approvals and other customary closing conditions.

Vinge acted as local counsel for Baxter. The Vinge team included Johan Winnerblad (partner), Jonas Bergström and Jonas Johansson together with, among others, Nicolina Kindblom, Gustav Jönsson, Rime Dreber, Emma Lindelöf, Daniel Unger, Helena Höök and Evelina Tejle.

Related

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026

Vinge has advised Resurs in connection with its strategic partnership with Kustom

Vinge has advised Resurs in connection with its strategic partnership with Kustom (formerly Klarna Checkout), a fast-growing player in the digital commerce sector. The partnership enables Resurs to accelerate its strategic development by offering a check-out solution to its merchants, built on Kustom’s market-leading infrastructure.
March 25, 2026

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of MedMera Bank AB

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of all shares in MedMera Bank AB from Kooperativa Förbundet for a total consideration of SEK 1,960 million. The transaction positions Morrow Bank as a leading Nordic platform in consumer finance with combined gross loans of SEK 28.2 billion.
March 24, 2026